Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

2(33.3%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05461443Not ApplicableCompleted

Lacticaseibacillus Rhamnosus GG Pili Study

Role: collaborator

NCT03996304Unknown

Health and Early Life Microbiota

Role: collaborator

NCT01031485Phase 3Completed

Bioactive Milk Peptides and Blood Pressure

Role: lead

NCT01738256Not ApplicableCompleted

Study of Effectiveness of Different Lifestyle Interventions for Health and Wellbeing

Role: collaborator

NCT01229917Phase 4Completed

Rhinovirus Study With Lactobacillus Rhamnosus GG

Role: lead

NCT01014676Phase 3Completed

Probiotics and Infections in Children Attending Day Care Centres

Role: lead

NCT01055080Not ApplicableCompleted

Insulin-free Cow Milk Formula in Prevention of Type 1 Diabetes Associated Autoimmunity - FINDIA Pilot Study

Role: collaborator

All 7 trials loaded